Sign in

CIK 0001411685

  • Non-accelerated filer
  • Smaller reporting company

Vistagen Therapeutics, Inc.

Sign in to watch
Ticker
VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NV
Entity type
Operating
EIN
205093315
Phone
+1 650-577-3600
Business address
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Former names
Excaliber Enterprises, Ltd.
  1. 4 Gift CHIEF OPERATING OFFICER gave 235,000 shares (gift)
  2. 4 Other disposition 10% owner disposed of 484,000 shares (other)
  3. 4 Option exercise PRES./CHIEF SCIENTIFIC OFFICER acquired 113,636 shares (option exercise)
  4. 4 Option exercise Director acquired 2,784 shares (option exercise)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3/A Insider 3/A
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 4 Open-market sale PRESIDENT sold 4,982,103 shares
  14. 4 Grant or award Director acquired 17,354 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 229,521 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award PRES./CHIEF SCIENTIFIC OFFICER acquired 545,416 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 76,087 shares (grant or award)

Page 14 of 15 · 282 filings